National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1347946

Government Disclaimer on use of this data

Case Details

VAERS ID: 1347946 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-05-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Cerebral haemorrhage, Platelet count, SARS-CoV-2 test, Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Haemorrhagic central nervous system vascular conditions (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-25
   Days after onset: 26
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arrhythmia absoluta; Arterial hypertension; Chronic renal insufficiency; Heart failure; Rectal carcinoma
Diagnostic Lab Data: Test Date: 20210330; Test Name: thrombocytopenia; Result Unstructured Data: Test Result:2; Comments: /nl; Test Date: 20210325; Test Name: SARS-CoV 2 test; Test Result: Negative
CDC Split Type: DEPFIZER INC2021574601

Write-up: suspicion on intracerebral bleeding; Thrombocytopenia until 2/nl; This is a spontaneous report from a non-contactable physician. A 85-year-old female patient received second dose of bnt162b2 (COMIRNATY) intramuscular on 15Mar2021 (Batch/Lot Number: Unknown) as 2nd dose, single for covid-19 immunisation. Medical history included arterial hypertension, state after rectum carcinoma from 2008, heart failure from 2008, chronic renal insufficiency from 2008, absolute arrhythmia from 2008. Historical vaccine included first dose of bnt162b2 (COMIRNATY) intramuscular on 16Feb2021 (Batch/Lot Number: Unknown) for covid-19 immunisation. Concomitant medications included furosemide (FUROSEMID); sodium picosulfate; candesartan; bisoprolol; apixaban; amlodipine; all taken for an unspecified indication, start and stop date were not reported. The patient experienced thrombocytopenia until 2/nl on 30Mar2021. Event seriousness criteria was death. Treatment received for the adverse event included imungglobulines and romiplostim. The lab test included sars-cov-2 test: negative on 25Mar2021. The patient died on 25Apr2021. Cause of death was reported as suspicion on intracerebral bleeding. An autopsy was not performed. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender''s Comments: Based on chronological connection to the vaccine, a causal relationship between events thrombocytopenia and intracerebral bleeding and BNT162B2 (COMIRNATY) vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: suspicion on intracerebral bleeding; Thrombocytopenia until 2/nl

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166